{
    "pmcid": "8225619",
    "qa_pairs": {
        "How does Rosetta contribute to the design of \u03b1\u03b2-proteins according to the paper?": [
            "It performs sequence-independent folding simulations and full-atom sequence design calculations.",
            "It predicts the tertiary structure of proteins based on primary sequences.",
            "It identifies potential binding sites for small molecules on protein surfaces.",
            "It simulates the dynamics of protein-ligand interactions in solution."
        ],
        "What challenge did the researchers encounter in their initial protein designs?": [
            "Strand swapping in \u03b2-sheets, indicating a need to incorporate global backbone strain considerations.",
            "Inability to achieve high-resolution NMR spectra for validation.",
            "Failure to generate any viable protein structures using Rosetta.",
            "Incompatibility between designed sequences and experimental expression systems."
        ],
        "What experimental technique was used to validate the computational models in the study?": [
            "NMR spectroscopy.",
            "X-ray crystallography.",
            "Cryo-electron microscopy.",
            "Mass spectrometry."
        ],
        "What is the main focus of the paper 'Role of backbone strain in de novo design of complex \u03b1/\u03b2 protein structures'?": [
            "The importance of considering global backbone strain in the design of larger \u03b1\u03b2-proteins.",
            "The development of new computational algorithms for protein folding.",
            "The discovery of new \u03b1\u03b2-proteins in natural systems.",
            "The analysis of protein-ligand interactions in drug design."
        ],
        "What potential application of the study's insights is mentioned in relation to SARS-CoV-2?": [
            "Informing the design of nanobodies targeting the SARS-CoV-2 spike protein.",
            "Developing vaccines against SARS-CoV-2.",
            "Creating antiviral drugs that inhibit SARS-CoV-2 replication.",
            "Engineering SARS-CoV-2 spike protein variants for research purposes."
        ]
    }
}